Emergency Med Medical News about acute chest pain; PTX3

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Long Pentraxin 3 (PTX3): A Novel Prognostic Inflammatory Marker for Mortality in Acute Chest Pain
Thrombosis and Haemostasis, 08/03/09

Brügger–Andersen T et al. – PTX3 is a new biomarker related to inflammation that, independently of BNP, strongly predicts long–term all–cause mortality in patients with acute chest pain. The combination of these two biomarkers enhances the prognostic value over either marker alone.

<< Previous
Patient satisfaction in an observation unit: the Consumer...

Next >>
Pre-hospital tracheal intubation in patients with traumatic brain...

Chest pain in primary care: Epidemiology and pre-work-up probabilities
The European Journal of General Practice, 11/05/09 Relevance Score: 83%

Gender Differences and Symptom Presentation in Noncardiac Chest Pain
The Female Patient, 10/07/09 Relevance Score: 82%

Usefulness of Age and Gender in the Early Triage of Patients With Acute Chest Pain Having Cardiac Computed Tomographic Angiography
The American Journal of Cardiology, 10/21/09 Relevance Score: 81%

Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome
Blood Coagulation & Fibrinolysis, 11/03/09 Relevance Score: 80%

Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain
Emergency Medicine Journal, 10/23/09 Relevance Score: 80%